USPTO serial 79281280
POLYPROX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 11, 2021
- Examiner
- LEASER, ANDREW C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with POLYPROX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
GB
GB
GB
GB
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals, chemical compounds and biologic compounds for use in industry and science; chemicals, chemical compounds and biologic compounds for use in industry and science, other than for medical or veterinary use; chemicals, chemical compounds and biologic compounds for scientific, laboratory or research purposes, in particular for use in the manufacture of pharmaceuticals and drugs for the treatment of cancer, including lung, colorectal and pancreatic cancers | ACTIVE | — |
| 005 | Pharmaceuticals, drugs and pharmaceutical preparations for the treatment of cancers, neurological diseases, metabolic diseases, cardiovascular diseases, autoimmune and inflammatory diseases; pharmaceuticals, drugs and pharmaceutical preparations for the treatment of cancer, including lung, colorectal and pancreatic cancers | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis, design and testing in the field of pharmaceuticals, drugs and pharmaceutical preparations; drug discovery and drug development services; conducting or providing research and development services for others in the field of pharmaceuticals, drugs and pharmaceutical preparations for the treatment of cancer, including lung, colorectal and pancreatic cancers | ACTIVE | — |
| 044 | Medical services; medical services connected with the treatment of cancer, including lung, colorectal and pancreatic cancers | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PolyProx Therapeutics Ltd
- Other trademarks owned by PolyProx Therapeutics Ltd
- Other trademarks owned by PolyProx Therapeutics Ltd
- Other trademarks owned by Laura Susan Itzhaki
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named POLYPROX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 11, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 4, 2022 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Sep 20, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 25, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 25, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 11, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 11, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 20, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 3, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 3, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 16, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 27, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 23, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 5, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 4, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 22, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 21, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 27, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 23, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 19, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |